PIK3CA and posterior cortical atrophy: PI3K is a common therapeutic target with existing drugs such as GDC-0941 and LY294002 which are reported to inhibit proliferation in human (Raynaud et al., 2009) and mouse transgenic (Renner et al., 2007) PCa cell lines.